161 related articles for article (PubMed ID: 28109853)
1. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
Rezende LM; Marson FA; Lima CS; Bertuzzo CS
Gene; 2017 Apr; 608():73-78. PubMed ID: 28109853
[TBL] [Abstract][Full Text] [Related]
2. Can MTHFR C677T and A1298C Polymorphisms Alter the Risk and Severity of Sporadic Breast Cancer in Brazilian Women?
Rezende LM; Marson FAL; Lima CSP; Bertuzzo CS
Clin Breast Cancer; 2017 Jul; 17(4):e199-e208. PubMed ID: 28330681
[TBL] [Abstract][Full Text] [Related]
3. Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.
Sghaier I; Zidi S; El-Ghali RM; Daldoul A; Aimagambetova G; Almawi WY
Gene; 2023 Jan; 851():146969. PubMed ID: 36261089
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
5. Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
Tsezou A; Tzetis M; Gennatas C; Giannatou E; Pampanos A; Malamis G; Kanavakis E; Kitsiou S
Breast; 2008 Apr; 17(2):159-66. PubMed ID: 17904846
[TBL] [Abstract][Full Text] [Related]
6. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
[TBL] [Abstract][Full Text] [Related]
7. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
Zheng Y; Huo D; Zhang J; Yoshimatsu TF; Niu Q; Olopade OI
PLoS One; 2012; 7(7):e40494. PubMed ID: 22792352
[TBL] [Abstract][Full Text] [Related]
8. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta (ESR2) gene polymorphism and susceptibility to dementia.
Ulhaq ZS; Garcia CP
Acta Neurol Belg; 2021 Oct; 121(5):1281-1293. PubMed ID: 32335869
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
Park SK; Andreotti G; Rashid A; Chen J; Rosenberg PS; Yu K; Olsen J; Gao YT; Deng J; Sakoda LC; Zhang M; Shen MC; Wang BS; Han TQ; Zhang BH; Yeager M; Chanock SJ; Hsing AW
Carcinogenesis; 2010 May; 31(5):842-6. PubMed ID: 20172949
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
Chae YK; Huang HY; Strickland P; Hoffman SC; Helzlsouer K
PLoS One; 2009 Aug; 4(8):e6523. PubMed ID: 19654868
[TBL] [Abstract][Full Text] [Related]
13. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
14.
Gallegos-Arreola MP; Zúñiga-González GM; Figuera LE; Puebla-Pérez AM; Márquez-Rosales MG; Gómez-Meda BC; Rosales-Reynoso MA
PeerJ; 2022; 10():e13379. PubMed ID: 35573183
[TBL] [Abstract][Full Text] [Related]
15. Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia.
Douma Z; Dallel M; Bahia W; Ben Salem A; Hachani Ben Ali F; Almawi WY; Lautier C; Haydar S; Grigorescu F; Mahjoub T
Gene; 2020 May; 741():144560. PubMed ID: 32169631
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
Yu KD; Rao NY; Chen AX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 126(1):37-45. PubMed ID: 20390341
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.
Maguire P; Margolin S; Skoglund J; Sun XF; Gustafsson JA; Børresen-Dale AL; Lindblom A
Breast Cancer Res Treat; 2005 Nov; 94(2):145-52. PubMed ID: 16261413
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study.
Bahia W; Soltani I; Haddad A; Soua A; Radhouani A; Mahdhi A; Ferchichi S
Gene; 2020 Apr; 736():144406. PubMed ID: 32007580
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Mol Carcinog; 2012 Oct; 51 Suppl 1():E104-17. PubMed ID: 22228197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
